Literature DB >> 19317738

Association of MIF promoter polymorphisms with childhood asthma in a northeastern Chinese population.

J Wu1, S Fu, X Ren, Y Jin, X Huang, X Zhang, J Bai, S Fu.   

Abstract

Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that plays an important role in pathogenesis of asthma. A high level of MIF has been detected in bronchoalveolar lavage fluid, serum and sputum in asthma. Polymorphisms associated with inflammatory diseases exist in the promoter region of MIF, which alter its expression. The aim of this study was to evaluate the potential relationship between functional polymorphisms of MIF and childhood asthma in a northeastern Chinese population. The study consisted of a set of 41 trios and an independent sample set of 189 childhood asthma patients and 261 healthy controls. We genotyped MIF-173G/C using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Additionally, MIF-794CATT(5-8) microsatellite polymorphism was genotyped by polyacrylamide gel electrophoresis (PAGE). A statistically significant difference in the distribution of the MIF-173C allele between patients and controls [P = 0.01, odds ratio (OR) = 1.55, 95% confidence interval (CI) = 1.13-2.18] was observed. In addition, the frequency of the MIF-173CC genotype was higher in asthmatic children (P < 0.01, OR = 3.37, 95% CI = 1.27-8.93). No difference in the distribution of CATT(5-8) was found between patients and healthy controls. Haplotype analysis showed that only the MIFCATT(7)-173C haplotype was associated with greater susceptibility to childhood asthma (P = 0.03, OR = 1.54, 95% CI 1.03-2.28). However, the transmission disequilibrium test confirmed a positive association between MIF-173G/C and childhood asthma (P = 0.005), and the absence of an association between the MIF-794CATT(5-8) and the disease. These preliminary results suggest an association between the MIF-173C allele and childhood asthma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19317738     DOI: 10.1111/j.1399-0039.2008.01206.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

Review 1.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

2.  Macrophage migration inhibitory factor gene polymorphisms and plasma levels in children with obstructive sleep apnea.

Authors:  Abdelnaby Khalyfa; Leila Kheirandish-Gozal; Oscar Sans Capdevila; Rakesh Bhattacharjee; David Gozal
Journal:  Pediatr Pulmonol       Date:  2012-03-26

3.  Role of macrophage migration inhibitory factor in the Th2 immune response to epicutaneous sensitization.

Authors:  Rituparna Das; Jeremy E Moss; Eve Robinson; Scott Roberts; Rebecca Levy; Yuka Mizue; Lin Leng; Courtney McDonald; Robert E Tigelaar; Christina A Herrick; Richard Bucala
Journal:  J Clin Immunol       Date:  2011-05-11       Impact factor: 8.317

4.  Evaluation of MIF -173 G/C Polymorphism in Turkish Patients with Ankylosing Spondylitis.

Authors:  Çevik Gürel; Ahmet İnanır; Ayşe Feyda Nursal; Akın Tekcan; Aydın Rüstemoğlu; Serbülent Yigit
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

5.  Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea.

Authors:  Jung Soo Kim; Jinyoung Choi; Hyung-Jin Hahn; Young-Bok Lee; Dong-Soo Yu; Jin-Wou Kim
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

6.  Association of macrophage migration inhibitory factor promoter polymorphism -173G/C with susceptibility to childhood asthma.

Authors:  Tarek Z El-Adly; Sally Kamal; Hala Selim; Shahira Botros
Journal:  Cent Eur J Immunol       Date:  2016-10-25       Impact factor: 2.085

7.  Association study of MIF promoter polymorphisms with suicide completers in the Japanese population.

Authors:  Naofumi Shimmyo; Akitoyo Hishimoto; Ikuo Otsuka; Satoshi Okazaki; Shuken Boku; Kentaro Mouri; Tadasu Horai; Motonori Takahashi; Yasuhiro Ueno; Osamu Shirakawa; Ichiro Sora
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-22       Impact factor: 2.570

8.  Serum macrophage migration inhibitory factor as a potential biomarker to evaluate therapeutic response in patients with allergic asthma: an exploratory study.

Authors:  Huiyuan Zhu; Shaochun Yan; Jingshuo Wu; Zhong Zhang; Xiaolin Li; Zheng Liu; Xing Ma; Lina Zhou; Lin Zhang; Mingming Feng; Yiwei Geng; Aixin Zhang; Sabina Janciauskiene; Aiguo Xu
Journal:  J Zhejiang Univ Sci B       Date:  2021-06-15       Impact factor: 3.066

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.